LOTIS 2 FOLLOW‐UP ANALYSIS: UPDATED RESULTS FROM A PHASE 2 STUDY OF LONCASTUXIMAB TESIRINE IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMAPier Luigi Zinzani, M. Hamadani, Carmelo Carlo‐Stella et al.|Hematological Oncology|2021Cited by 8